Janux Therapeutics, Inc.

Historical 13F Holders

Symbol
JANX
CUSIP
47103J105
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 47103J105 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
19.9% 3/10/2025
Event 3/6/2025
BlackRock, Inc. 13G/A 6.7% 7/28/2026
Event 6/30/2026
Prosight Management, LP 13G/A
5.2% 11/13/2026
Event 11/10/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Paradigm Biocapital Advisors LP 13G/A
4.9% 8/14/2025
Event 6/30/2025
Adage Capital Management, L.P. 13G/A
4.3% 8/12/2025
Event 6/30/2025
FMR LLC 13G/A
4.2% 5/6/2026
Event 3/31/2026
State Street Corp 13G 4.1% 5/12/2026
Event 3/31/2026
Point72 Asset Management, L.P. 13G/A
3.3% 8/14/2026
Event 6/30/2026
Janus Henderson Group Ltd. 13G/A 0.3% 8/13/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 206 61.3 M $1.06B
2026 Q2 199 60.8 M $933M
2026 Q1 193 59.6 M $828M
2025 Q4 181 62.2 M $860M
2025 Q3 175 65.2 M $1.59B
2025 Q2 178 65.5 M $1.51B
2025 Q1 185 66.5 M $1.81B
2024 Q4 220 64.1 M $3.43B
2024 Q3 163 45.6 M $2.07B
2024 Q2 157 44.7 M $1.87B
2024 Q1 123 42.3 M $1.59B
2023 Q4 66 33.5 M $360M
2023 Q3 59 35.1 M $354M
2023 Q2 55 30.5 M $362M
2023 Q1 49 30.5 M $370M
2022 Q4 51 29.0 M $381M
2022 Q3 50 29.6 M $400M
2022 Q2 45 28.9 M $353M
2022 Q1 48 28.4 M $407M
2021 Q4 47 27.5 M $542M
2021 Q3 46 26.5 M $571M
2021 Q2 31 24.7 M $614M